Nexviazyme for intravenous infusion 100mg, containing avalglucosidase alpha, is a Sanofi-manufactured enzyme replacement therapy for late-onset Pompe disease. It is administered as an intravenous infusion, with a YJ code of 3959425D1028 and standard of 100mg x 1 bottle.
Nexviazyme for intravenous infusion 100mg
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →